Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 07/27 10:03:39 pm
76.462 EUR   -0.14%
01:30pDJSANOFI : 2Q 2016 -- Forecast
07/26 SANOFI : India ends in green; SC refuses early hearing
07/26 Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

SANOFI : PRESS RELEASE : Former Research Chemist At Global Pharmaceutical Company Sentenced To 18 Months In Prison For Theft Of Trade Secrets

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/07/2012 | 07:17pm CEST

United States Attorney

District of New Jersey

FOR IMMEDIATE RELEASE CONTACT: Rebekah Carmichael

May 7, 2012 Office of Public Affairs

www.justice.gov/usao/nj (973) 645-2888

FORMER RESEARCH CHEMIST AT GLOBAL PHARMACEUTICAL COMPANY

SENTENCED TO 18 MONTHS IN PRISON FOR THEFT OF TRADE SECRETS

TRENTON, N.J. - A former research chemist with global pharmaceutical company

sanofi-aventis ("sanofi") was sentenced today to 18 months in prison for stealing sanofi's trade

secrets and making them available for sale through Abby Pharmatech, Inc. ("Abby"), the U.S.

subsidiary of a Chinese chemicals company, U.S. Attorney Paul J. Fishman announced.

Yuan Li, 30, of Somerset, N.J., a Chinese national, previously pleaded guilty to an

Information charging her with one count of theft of trade secrets. Li entered her guilty plea

before U.S. District Judge Joel A. Pisano, who also imposed the sentence today in Trenton

federal court.

According to documents filed in this case and statements made in court:

Sanofi is a global healthcare company with U.S. headquarters in Bridgewater, N.J.

Among other things, sanofi is engaged in the development, manufacture and marketing of

healthcare products including the prescription drugs Allegra, Plavix, Copaxone and Ambien.

Li worked as a research scientist at sanofi's Bridgewater headquarters from October 2006

through June 2011, where she directly assisted in the development of a number of compounds

that sanofi viewed as potential building blocks for future drugs. These compounds were sanofi's

trade secrets and had not been disclosed outside of sanofi in any manner, including by means of a

patent application.

While employed at sanofi, Li was also a 50 percent partner in Abby, which is engaged in

the sale and distribution of pharmaceuticals.

Li admitted that between January 2010 and June 2011, she accessed an internal sanofi

database and downloaded information related to a number of sanofi compounds, including their

chemical structures, onto her sanofi-issued laptop computer. She also admitted she then

transferred the information to her personal home computer by sending it to her personal e-mail

address or via a USB thumb drive.

Li acknowledged that she made the stolen compounds available for sale on Abby's

website.

In addition to the prison term, Judge Pisano sentenced Li to serve two years of supervised

release and ordered her to pay $131,000 in restitution.

U.S. Attorney Fishman credited special agents of the FBI, under the direction of Special

Agent in Charge Michael B. Ward, with the investigation.

The government is represented by Assistant U.S. Attorney Gurbir S. Grewal of the

Computer Hacking and Intellectual Property Section of the U.S. Attorney's Office Economic

Crimes Unit in Newark.

12-159 ###

Defense counsel: Paul Brickfield Esq., River Edge, N.J.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
01:30pDJSANOFI : 2Q 2016 -- Forecast
07/26 SANOFI : India ends in green; SC refuses early hearing
07/26 Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say
07/26SANOFI SA : half-yearly earnings release
07/26 SANOFI PASTEUR : Ships First of its 2016-2017 Seasonal Influenza Vaccine Doses i..
07/25 SANOFI : India zooms 2.7% after strong Q1 nos
07/23 SANOFI INDIA : Q2 NET UP 33% AT Rs85 CRORE
07/22 PROMIS NEUROSCIENCES : Announces Appointment of Dr. Johanne Kaplan as Chief Deve..
07/21 SANOFI : Information concerning the total number of voting rights and shares, pr..
07/21 JUNIPER PHARMACEUTICALS : Appoints Alicia Secor President and Chief Executive Of..
More news
Sector news : Pharmaceuticals - NEC
11:00pDJALERE : Faces Criminal Probe Over Medicare, Medicaid Billing -- Update
10:56pDJAmgen Profit Rises 13%, 2016 Outlook Raised
10:56pDJALERE : Faces Criminal Probe Over Medicare, Medicaid Billing
10:36pDJFacebook Posts Strong Profit and Revenue Growth
09:45p Teva purchase of Allergan generics business gets OK with conditions
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
01:10p MANNKIND : Beware Of Dog
08:18a MY EARNINGS GAME PLAN : July 28-29
07/25 Is Biotech Finally Ready To Move Higher?
07/25 RETIREMENT STRATEGY : 5 Pharmaceutical Dividends To Buy Here
07/22 MannKind - Afrezza Sales Pacing Below My Bearish Line - Reality May Sting
Advertisement
Financials (€)
Sales 2016 37 154 M
EBIT 2016 9 361 M
Net income 2016 5 093 M
Debt 2016 5 594 M
Yield 2016 3,92%
P/E ratio 2016 17,76
P/E ratio 2017 16,14
EV / Sales 2016 2,81x
EV / Sales 2017 2,76x
Capitalization 98 692 M
More Financials
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 85,0 €
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
JÚr˘me Contamine Chief Financial Officer & EVP-Finance
Elias E. Zerhouni President-Global Research & Development
Yong-Jun Liu Head-Global Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-2.58%108 516
JOHNSON & JOHNSON21.84%344 243
PFIZER INC.14.10%223 368
NOVARTIS AG-5.30%219 971
ROCHE HOLDING LTD.-9.99%218 902
MERCK & CO., INC.10.49%161 542
More Results